Daher M, Mekhael E, El-Othmani M
Hip Pelvis. 2024; 36(4):260-272.
PMID: 39620567
PMC: 11638754.
DOI: 10.5371/hp.2024.36.4.260.
Di Martino A, Valtetsiotis K, Rossomando V, Brunello M, Bordini B, DAgostino C
Biomedicines. 2024; 12(8).
PMID: 39200242
PMC: 11351197.
DOI: 10.3390/biomedicines12081778.
Tang Y, Jin Z, Lu Y, Chen L, Lv S, Xu T
Orthop Surg. 2024; 16(10):2344-2354.
PMID: 39056482
PMC: 11456730.
DOI: 10.1111/os.14165.
Pegios V, Kenanidis E, Tsotsolis S, Potoupnis M, Tsiridis E
EFORT Open Rev. 2023; 8(11):798-808.
PMID: 37909705
PMC: 10646521.
DOI: 10.1530/EOR-22-0121.
Li X, Han J, Shi X, Bi Z, Liu J
Arch Osteoporos. 2023; 18(1):37.
PMID: 36840811
DOI: 10.1007/s11657-023-01227-9.
Zoledronic Acid Ameliorates the Bone Turnover Activity and Periprosthetic Bone Preservation in Cementless Total Hip Arthroplasty.
Hsu A, Yen C, Kuo F, Wu C, Huang T, Cheng J
Pharmaceuticals (Basel). 2022; 15(4).
PMID: 35455417
PMC: 9030653.
DOI: 10.3390/ph15040420.
Bisphosphonates in Total Joint Arthroplasty: A Review of Their Use and Complications.
McDonald C, Lemme N, Testa E, Aaron R, Hartnett D, Cohen E
Arthroplast Today. 2022; 14:133-139.
PMID: 35308048
PMC: 8927797.
DOI: 10.1016/j.artd.2022.02.003.
High periprosthetic bone mineral density measured in immediate postoperative period may not guarantee less periprosthetic bone loss in the proximal femur after cementless total hip arthroplasty - A retrospective study.
Fu G, Ma Y, Liao J, Xue Y, Li M, Li Q
Arthroplasty. 2022; 2(1):2.
PMID: 35236466
PMC: 8796644.
DOI: 10.1186/s42836-020-0023-3.
Zoledronic Acid for Periprosthetic Bone Mineral Density Changes in Patients With Osteoporosis After Hip Arthroplasty-An Updated Meta-Analysis of Six Randomized Controlled Trials.
Liu Y, Xu J, Li M, Wu L, Zeng Y, Shen B
Front Med (Lausanne). 2022; 8:801282.
PMID: 35004777
PMC: 8733298.
DOI: 10.3389/fmed.2021.801282.
Raloxifene Prevents Early Periprosthetic Bone Loss for Postmenopausal Women after Uncemented Total Hip Arthroplasty: A Randomized Placebo-Controlled Clinical Trial.
Gong L, Zhang Y, Yang N, Qian H, Zhang L, Tan M
Orthop Surg. 2020; 12(4):1074-1083.
PMID: 32686337
PMC: 7454213.
DOI: 10.1111/os.12696.
Effects of Systemic or Local Administration of Zoledronate on Implant Osseointegration: A Preclinical Meta-Analysis.
He Y, Bao W, Wu X, Huang W, Chen H, Li Z
Biomed Res Int. 2019; 2019:9541485.
PMID: 31663000
PMC: 6778941.
DOI: 10.1155/2019/9541485.
Efficiency of Zoledronic Acid in Inhibiting Accelerated Periprosthetic Bone Loss After Cementless Total Hip Arthroplasty in Osteoporotic Patients: A Prospective, Cohort Study.
Fu G, Lin L, Sheng P, Li C, Zhang J, Shen J
Orthop Surg. 2019; 11(4):653-663.
PMID: 31456320
PMC: 6712387.
DOI: 10.1111/os.12513.
Zoledronate induces cell cycle arrest and differentiation by upregulating p21 in mouse MC3T3-E1 preosteoblasts.
Huang K, Huang T, Chuang P, Yang T, Chang S
Int J Med Sci. 2019; 16(5):751-756.
PMID: 31217743
PMC: 6566742.
DOI: 10.7150/ijms.32612.
Effects of zoledronic acid on bone mineral density around prostheses and bone metabolism markers after primary total hip arthroplasty in females with postmenopausal osteoporosis.
Zhou W, Liu Y, Guo X, Yang H, Xu Y, Geng D
Osteoporos Int. 2019; 30(8):1581-1589.
PMID: 31115592
DOI: 10.1007/s00198-019-05005-7.
To withhold or to implement bisphosphonate after cementless hip arthroplasty: a dilemma in elderly hip fracture patients.
Lee Y, Kim T, Ha Y, Koo K
J Orthop Surg Res. 2019; 14(1):66.
PMID: 30808386
PMC: 6390618.
DOI: 10.1186/s13018-019-1104-2.
Effects of bisphosphonates in preventing periprosthetic bone loss following total hip arthroplasty: a systematic review and meta-analysis.
Shi J, Liang G, Huang R, Liao L, Qin D
J Orthop Surg Res. 2018; 13(1):225.
PMID: 30180868
PMC: 6123982.
DOI: 10.1186/s13018-018-0918-7.
Restoration of proximal periprosthetic bone loss by denosumab in cementless total hip arthroplasty.
Nagoya S, Tateda K, Okazaki S, Kosukegawa I, Shimizu J, Yamashita T
Eur J Orthop Surg Traumatol. 2018; 28(8):1601-1607.
PMID: 29774416
DOI: 10.1007/s00590-018-2223-x.
Bisphosphonates for the preservation of periprosthetic bone mineral density after total joint arthroplasty: a meta-analysis of 25 randomized controlled trials.
Shi M, Chen L, Xin Z, Wang Y, Wang W, Yan S
Osteoporos Int. 2018; 29(7):1525-1537.
PMID: 29654342
DOI: 10.1007/s00198-018-4488-7.
Bone turnover and periprosthetic bone loss after cementless total hip arthroplasty can be restored by zoledronic acid: a prospective, randomized, open-label, controlled trial.
Huang T, Wang C, Shih H, Chang Y, Huang K, Peng K
BMC Musculoskelet Disord. 2017; 18(1):209.
PMID: 28532408
PMC: 5441106.
DOI: 10.1186/s12891-017-1577-2.
Effects of teriparatide on cementless bipolar hemiarthroplasty in patients with osteoporotic femoral neck fractures.
Huang T, Huang K, Lin S, Chuang P, Shih H, Lee M
BMC Musculoskelet Disord. 2016; 17:300.
PMID: 27435235
PMC: 4952237.
DOI: 10.1186/s12891-016-1149-x.
